:: CLDF ::

Home | Contact Us | Bookmark

HCC

HRS

NASH

PBC

THROMBOCYTOPENIA

Centers of Educational Expertise

Live CME Meetings Webcasts Slide Library Abstract Library Annotations Committee Members

Conference Highlights

HBV |Abstract Library

The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors.

Abstract Details


	The efficacy of Tenofivir to prevent perinatal transmission in chronic hepatitis B mothers'. a clinical perspective

Mubarak G¹, Ferstenberg R². Hepatology. 2018 Aug 2. doi: 10.1002/hep.30138. [Epub ahead of print]

Author information

1 State University of New York Downstate, Medical Center, Internal medicine.

2 Kings County Hospital Center, Gastroenterology SUNY Downstate Medical Center, Gastroenterology.

Abstract

With great satisfaction, we read The April, 2018 AASLD guidelines for the management of chronic hepatitis B propose that pregnant women with hepatitis B receive tenofovir in the third trimester, for viral loads greater than 200,000 International Units/ milliliter.

HEPATITIS

HCC

HRS

NASH

PBC

THROMBOCYTOPENIA

About CLDF

Board of Advisors/Faculty

2019 GI Fellow Board of Advisors

Other Resources

Liver News Library

Journal Abstracts

Hep C Link to Care

Centers of
Educational Expertise

Hepatology

Substance Use Disorder

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2020 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.